This webcast features: Martin Lobedann, PhD, Process Technology Consultant, Sartorius.
Process intensification in biomanufacturing is becoming more prevalent as market demand for therapies and the cost to deliver them increases.
Typically, the move from batch processing to intensified, continuous processing has been seen as an all-or-nothing approach, with little consideration for something in between. Literature concerning process intensification is also relatively crowded, with multiple terms used to describe process intensification like continuous, connected, intensified, or steady-state. Often, these terms are used inappropriately or interchangeably, which generates confusion in the field.
This webinar proposes the use of Sartorius’ multi-tiered leveling classification for process intensification, similar to the automation industry, to improve understanding in the biopharma industry and help create a standard platform for intensification moving forward.
Key Takeaways:
Introduces the various levels of intensification by discussing key technologies and systems within the industry.
Shows the effect of different intensification levels on process productivity using a model of a monoclonal antibody-based DSP platform.
Just fill out the form below to view the recorded webcast now.